Gender differences in selected zinc metabolism parameters in patients with mild primary arterial hypertension

Biological Trace Element Research

Volumn 114, Issue 1-3, 2006, Pages 55-63

  Tubek, Sławomir ^a,b  

^a UNIVERSITY OF OPOLE   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Age; Aldosterone; Angiotensin converting enzyme; Mild arterial hypertension; Renin plasma activity; Sex differences; Zinc; Zinc efflux from lymphocytes

Indexed keywords

ALDOSTERONE; CHYMOSIN; DIPEPTIDYL CARBOXYPEPTIDASE; OUABAIN; POTASSIUM; SODIUM; ZINC;

ADOLESCENT; ADULT; ALDOSTERONE BLOOD LEVEL; ARTERIAL PRESSURE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CORRELATION COEFFICIENT; DIASTOLIC BLOOD PRESSURE; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HYPERTENSION; LYMPHOCYTE; MALE; POTASSIUM BLOOD LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SERUM; SEX; SEX DIFFERENCE; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; ZINC BLOOD LEVEL; ZINC METABOLISM;

STROPHANTHUS GRATUS;

EID: 33846233464     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:114:1:55     Document Type: Article

References (29)

1. S. Tubek, The zinc content in lymphocytes and the activity of zinc ions efflux from lymphocytes in primary arterial hypertension, Biol. Trace Element Res. 107, 89-99 (2005).
2. S. Tubek, Selected zinc metabolism parameters in relation to insulin and renin - angiotensin - aldosterone system and blood pressure in healthy subjects: sex differences, Biol. Trace Element Res., 114, 65-72 (2006).
3. J. Y. Lee, T. B. Cole, R. D. Palmiter, S. W. Suh, and J. Y. Koh, Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice, Proc. Natl. Acad. Sci. USA 99, 7705-7710 (2002).
4. E. D. Thompson, P. E. Olsson, G. D. Mayer, P. J. Walsh, E. Burge, and C. Hogstrand, Effects of 17 beta-estradiol on levels and distribution of metallothionein and zinc in squirrelfish, Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R527-R535 (2001).
5. J. G. Henrotte, M. Santarromana, G. Franck, P. Guicheney, R. Boulu, and R. Bourdon, High cardiac zinc level in spontaneously hypertensive rats, J. Hypertens. 10, 553-559 (1992).
6. B. Gil-Extremera, A. Maldonado, M Ruiz-Martinez, and M. A. Rubio, Zinc in adult human serum in Spain, Rev. Esp. Fisiol. 45, 217-219 (1989) (abstract).
7. B. de Mateo Silleras, A. Perez Gracia, and A. Mijan de la Torre, The zinc status in a selected Spanish population. A multivariate analysis, Nutr. Hosp. 15, 32-41 (2000) (abstract).
8. T. Magalova, A. Brtkova, A. Bederova, I. Kajaba, and I. Puchonova, Serum copper and zinc in industrial centers in Slovakia, Biol. Trace Element Res. 40, 225-235 (1994).
9. J. F., Brun, C. Dieu-Cambrezy, A. Charpiat, et al., Biol. Trace Element Res. 47, 273-278 (1995).
10. R. S. Gibson, M. Skeaff, and S. Williams, Interrelationship of indices of body composition nad zinc status in 11-yr-old New Zealand children, Biol. Trace Element Res. 75, 65-77 (2000).
11. A. Boyum, Isolation of mononuclear cells and granulocytes from blood. II. Isolation of mononuclear cells by centrifugation and of granulocytes by combining centrifugation and sendimentation og 1 g, Scand. J. Clin. Lab. Invest. 21(Suppl. 97), 77-85 (1968).
12. A. Noworolska, Antygeny onkoplodowe w komórkach szeregu mielocytarnego, Doctoral thesis. AM Wrocl/aw (1984) (in Polish).
13. A. M. Heagerty, R. F. Bing, M. Miluer, H. Thuston, and J. W. Shales, Leucocyte membrane sodium transport in normotensive populations; dissociation of abnormalities of sodium efflux from raised blood pressure, Lancet 2, 894-905, (1982).
14. Perkin-Elmer, Analytical Methods for Atomic Absorption Spectrometry, Perkin-Elmer, Norwalk, CT (1971).
15. N. Kaplan, Clinical Hypertension, 6th ed., William & Wilkins, Baltimore, pp. 97-98 (1994).
16. M. E. Wastney, S. Ahmed, and R. I. Henkin, Changes in regulation of human zinc metabolism with age, Am. J. Physiol. 263(5 Pt. 2), R1162-R1168 (1992).
17. P. Darlu, J. M. Lalouel, J. G. Henrotte, and D. C. Rao, A genetic study of red blood zinc concentration in man, Hum. Heredity 33, 311-320 (1983).
18. R. D. Lindeman, M. L. Clark, and J. P. Colmore, Influence of age and sex on plasma and red-cell zinc concentration, J. Gerontol. 26, 358-363 (1971).
19. S. Tubek, The zinc content in lymphocytes and the activity of zinc ions efflux from lymphocytes in primary arterial hypertension, Biol. Trace Element Res. 107, 89-99 (2005).
20. M. G. Matera, D. De Santis, S. Maione, et al., Antihypertensive drugs and urinary excretion of zinc in genetically hypertensive rats, Curr. Ther. Res. 46, 667-680 (1989).
21. G. Vivoli, M. Bergomi, S. Rovesti, M. Pinotti, and E. Caselgrandi, Zinc, copper and zincor copper-dependent enzymes in human hypertension, Biol. Trace Element Res. 49, 97-106 (1995).
22. G. J. L Zozaya., M. P. Viluria, and A. Castro, Urinary excretion of zinc in patients with essential arterial hypertension, Res. Commun. Chem. Pathol. Pharmacol. 48, 445-453 (1985).
23. M. D. Chen, P. Y. Lin, C. T. Tsou, J. J. Wang, and W. H. Lin, Selected metals status in patients with nonisulin-dependent diabetes mellitus, Biol. Trace Element Res. 50, 119-124 (1995).
24. W. B. Kinlaw, A. S. Levine, and J. E. Morley, Abnormal zinc metabolism in type Idiabetes mellitus, Am. J. Med. 75, 273-280 (1983).
25. N. Ddo Marreiro, M. Fisberg, and S. M. Cozzolino, Zinc nuritional status in obese children and adolescents, Biol. Trace Element Res. 86, 107-122 (2002).
26. N. Ddo Marreiro, M. Fisberg, and S. M. Cozzolino, Zinc nuritional status and its ralationship with hyperinsulinemia in obese children and adolescents, Biol. Trace Element Res., 100, 137-149 (2004).
27. M. Hocke, K. Winnefeld, and H. Bosseckert. Zinc concentration in serum and leucocytes in chronic inflammatory diseases, J. Trace Element Med. Biol. 9, 112-116 (1995).
28. W. R. Harlan, J. R. Landis, R. L. Schmouder, N. G. Goldstein, and L. C. Harlan, Blood lead and blood pressure. Relationship in the adolescent and adult US population, JAMA 253, 530-534 (1985).
29. S. Tubek, Differences in selected zinc metabolism parameters in obese and normal-weight hypertensive patients following treatment with spironolactone. Biol. Trace Element Res. 114, 135-141 (2006).